Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients.

about

Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.

P2860

Q55250322-0BC7206B-02FF-424C-B0D4-C90B9D230ABD

P2860

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients.

Item

http://www.wikidata.org/entity/Q41697121

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Value of Measuring Anti-Carbam ...... n on Early Arthritis Patients.

@en

type

Item

label

Value of Measuring Anti-Carbam ...... n on Early Arthritis Patients.

@en

prefLabel

Value of Measuring Anti-Carbam ...... n on Early Arthritis Patients.

@en

P1476

Value of Measuring Anti-Carbam ...... on on Early Arthritis Patients

@en

P2093

Alejandro Balsa

http://www.w3.org/2001/XMLSchema#string

Alejandro Villalba

http://www.w3.org/2001/XMLSchema#string

Ana M Ortiz

http://www.w3.org/2001/XMLSchema#string

Ana Martínez-Feito

http://www.w3.org/2001/XMLSchema#string

Cristina Regueiro

http://www.w3.org/2001/XMLSchema#string

Diana Peiteado

http://www.w3.org/2001/XMLSchema#string

Dora Pascual-Salcedo

http://www.w3.org/2001/XMLSchema#string

Isidoro González-Alvaro

http://www.w3.org/2001/XMLSchema#string

Laura Nuño

http://www.w3.org/2001/XMLSchema#string

P2860

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Interleukin 15 levels in serum may predict a severe disease course in patients with early arthritis

Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.

Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients

Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage.

Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis.

Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.

Anti-Carbamylated Protein Antibodies as a Reproducible Independent Type of Rheumatoid Arthritis Autoantibodies.

Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.

P2888

s41598-017-09657-5

P304

12023

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-09657-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Gonzalez

P577

2017-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28931886

http://www.w3.org/2001/XMLSchema#string

P932

5607236

http://www.w3.org/2001/XMLSchema#string

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients.

about

P2860

P2860

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932